Lack of efficacy of a decongestant-antihistamine combination for otitis media with effusion ("secretory" otitis media) in children. Results of a double-blind, randomized trial. 1983

E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers

In a double-blind, randomized trial of 553 infants and children who had otitis media with effusion ("secretory" otitis media), we compared the efficacy of a four-week course of an oral decongestant-antihistamine combination (pseudoephedrine hydrochloride, 4 mg per kilogram of body weight per day, and chlorpheniramine maleate, 0.35 mg per kilogram per day) with that of placebo. Among patients with initially unilateral disease, resolution of middle-ear effusion occurred at four weeks in 38 per cent of those treated with placebo and 34 per cent of those treated with drug (P = 0.74). Among patients with initially bilateral disease the corresponding proportions were 19 and 21 per cent, respectively (P = 0.67). Side effects were reported more often among drug-treated than placebo-treated patients. Decongestant-antihistamine combinations do not appear to be indicated for the treatment of otitis media with effusion in infants and children.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D010033 Otitis Media Inflammation of the MIDDLE EAR including the AUDITORY OSSICLES and the EUSTACHIAN TUBE. Middle Ear Inflammation,Inflammation, Middle Ear
D010034 Otitis Media with Effusion Inflammation of the middle ear with a clear pale yellow-colored transudate. Middle Ear Effusion,Otitis Media, Secretory,Otitis Media, Serous,Ear Effusion, Middle,Ear Effusions, Middle,Effusion, Middle Ear,Effusions, Middle Ear,Middle Ear Effusions,Secretory Otitis Media,Serous Otitis Media
D010349 Patient Compliance Voluntary cooperation of the patient in following a prescribed regimen. Client Adherence,Client Compliance,Non-Adherent Patient,Patient Adherence,Patient Cooperation,Patient Noncompliance,Patient Non-Adherence,Patient Non-Compliance,Patient Nonadherence,Therapeutic Compliance,Treatment Compliance,Adherence, Client,Adherence, Patient,Client Compliances,Compliance, Client,Compliance, Patient,Compliance, Therapeutic,Compliance, Treatment,Cooperation, Patient,Non Adherent Patient,Non-Adherence, Patient,Non-Adherent Patients,Non-Compliance, Patient,Nonadherence, Patient,Noncompliance, Patient,Patient Non Adherence,Patient Non Compliance,Patient, Non-Adherent,Therapeutic Compliances,Treatment Compliances
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002744 Chlorpheniramine A histamine H1 antagonist used in allergic reactions, hay fever, rhinitis, urticaria, and asthma. It has also been used in veterinary applications. One of the most widely used of the classical antihistaminics, it generally causes less drowsiness and sedation than PROMETHAZINE. Chlorphenamine,Chlorprophenpyridamine,Aller-Chlor,Antihistaminico Llorens,Chlo-Amine,Chlor-100,Chlor-Trimeton,Chlor-Tripolon,Chlorpheniramine Maleate,Chlorpheniramine Tannate,Chlorpro,Chlorspan 12,Chlortab-4,Cloro-Trimeton,Efidac 24,Kloromin,Piriton,Teldrin,Maleate, Chlorpheniramine,Tannate, Chlorpheniramine
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic

Related Publications

E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers
February 1987, The New England journal of medicine,
E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers
June 1983, The New England journal of medicine,
E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers
October 1981, The Journal of otolaryngology,
E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers
September 1979, International journal of pediatric otorhinolaryngology,
E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers
April 1989, Archives of otolaryngology--head & neck surgery,
E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers
March 1979, Pediatrics,
E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers
September 1996, Clinical pediatrics,
E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers
February 1983, The Journal of pediatrics,
E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers
October 1990, Canadian family physician Medecin de famille canadien,
E I Cantekin, and E M Mandel, and C D Bluestone, and H E Rockette, and J L Paradise, and S E Stool, and T J Fria, and K D Rogers
November 1988, Canadian family physician Medecin de famille canadien,
Copied contents to your clipboard!